To investigate the potential mechanism underlying the role of IGF2BP3 in bladder cancer proliferation and chemotherapy resistance, we initially conducted RNA-seq analysis on T24 cells with IGF2BP3 knockdown and control groups, each consisting of three biological replicates. The gene discussed is IGF2BP3; the disease is urinary bladder carcinoma.